Skip to main content
. Author manuscript; available in PMC: 2021 Jul 28.
Published in final edited form as: J Med Chem. 2016 Jan 13;59(2):578–591. doi: 10.1021/acs.jmedchem.5b01153

Table 4.

Cytochrome P450 Inhibition by Compound (+)-22a.a

CYP Isoform (Substrate) Inhibition (%) ± SEM
1A2 (Phenacetin) 86.0 ± 0.25
2C9 (Tolbutamide) 29.2 ± 2.2
2C19 (Mephenytoin) 32.0 ± 5.3
2D6 (Dextromethorphan) 43.5 ± 3.0
3A4 (Midazolam) 3.4 ± 1.6
a

Compound (+)-20a was tested at 10 μM; concentration of human liver microsomes was 0.2 mg/mL; concentration of phenacetin, tolbutamide, mephenytoin, dextromethorphan, and midazolam was 40, 200, 50, 10, and 5 μM respectively.